Wellgistics Health (NASDAQ:WGRX – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Friday.
Wellgistics Health Stock Performance
Wellgistics Health stock opened at $0.9450 on Friday. The business has a 50-day moving average price of $0.93. The company has a debt-to-equity ratio of 11.16, a current ratio of 0.32 and a quick ratio of 0.15. Wellgistics Health has a 12-month low of $0.6150 and a 12-month high of $7.04.
Wellgistics Health (NASDAQ:WGRX – Get Free Report) last issued its quarterly earnings results on Tuesday, August 19th. The company reported ($0.11) earnings per share (EPS) for the quarter. The firm had revenue of $7.79 million during the quarter.
About Wellgistics Health
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.
Featured Articles
- Five stocks we like better than Wellgistics Health
- How to Invest in the Best Canadian Stocks
- Royal Caribbean Earnings Beat Fuels Strong 2025 Outlook
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Alphabet’s Breakout Potential: From Laggard to AI Leader
- Buy P&G Now, Before It Sets A New All-Time High
- TJX Stock Price Hits Fresh High, Signals More Highs to Follow
Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.
